Check out your Company Bowl for anonymous work chats.
Check out the New York Times story on the work we’re doing to develop a T-cell test as a better indicator for past #COVID19 infection. Proud of our Adaptive team!
We are pleased to announce our collaboration with GSK to measure minimal residual disease (MRD) with our clonoSEQ Assay across their portfolio of hematology and oncology products: https://rebrand.ly/6e9c3 clonoSEQ is FDA-cleared to assess MRD in patients with CLL, MM, or B-ALL. For imp. info, incl. sample types & test limitations: https://rb.gy/8tju9y
Virtual Halloween celebrations!
We are so honored and proud to be selected as one of the 2020 Best Places to Work in Washington by the Puget Sound Business Journal! At Adaptive, our company culture is at the core of what we do and is proving to be stronger than ever as we navigate through the COVID-19 pandemic together. #BeAdaptive #Got2Adapt #BPTW
We're excited to announce expanded FDA clearance for the clonoSEQ Assay to assess Minimal Residual Disease (MRD) in patients with Chronic Lymphocytic Leukemia, in addition to Multiple Myeloma and ALL. #CLL clearance includes blood testing and clonoSEQ patients can now access convenient and safe blood draws at home or via LabCorp Patient Service Centers: https://rebrand.ly/3cc03 clonoSEQ is FDA-cleared to assess MRD in patients with CLL, MM, or B-ALL. For important info, incl. sample types & test limitations: https://rb.gy/8tju9y
It?s official! We?ve launched immunoSEQ T-MAP COVID, our new proprietary research and data analysis service for vaccine developers! #Got2Adapt #InThisTogether
Read CSO Harlan Robins’ reflection on our partnership with Microsoft to decode the population-wide immune response to the #COVID19 virus and making all data freely available to researchers worldwide through the ImmuneCODE database. Learn more about ImmuneCODE: https://rebrand.ly/ec6dc #InThisTogether
As we celebrate Pride Month, we are spotlighting the Adaptive LGBTQ+ community and sharing their unique perspectives. This week, meet Beau: “Every time I hold a patient’s sample, the importance of our work at Adaptive is clear. At Adaptive, I get to be a part of a team making a difference in advancing clinical diagnoses and research outcomes. I also get to celebrate my queer identity and hold my head high when I come to work.” – Beau, Clinical Lab Technician #Pride #pride2020 #prideisinourDNA #AdaptivePride
We're launching our groundbreaking ImmuneCODE database with Microsoft that will share the population-wide immune response to #COVID19. De-identified data is being made freely available to the global research community to accelerate solutions for the virus. https://rebrand.ly/f0efd #InThisTogether
We are proud to partner with industry leaders to respond to this global health pandemic.
